Similar articles

• Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study.

  Park JR, Scott JR, Stewart CF, London WB, Naranjo A, Santana VM, Shaw PJ, Cohn SL, Matthay KK. Park JR, et al. J Clin Oncol. 2011 Nov 20;29(33):4351-7. doi: 10.1200/JCO.2010.34.3293. Epub 2011 Oct 17. J Clin Oncol. 2011. PMID: 22010014 Free PMC article. Clinical Trial.
• Optimization of liposomal topotecan for use in treating neuroblastoma.

  Chernov L, Deyell RJ, Anantha M, Dos Santos N, Gilabert-Oriol R, Bally MB. Chernov L, et al. Cancer Med. 2017 Jun;6(6):1240-1254. doi: 10.1002/cam4.1083. Epub 2017 May 23. Cancer Med. 2017. PMID: 28544814 Free PMC article.
• Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.

  Kushner BH, Cheung NK, Kramer K, Dunkel IJ, Calleja E, Boulad F. Kushner BH, et al. Bone Marrow Transplant. 2001 Sep;28(6):551-6. doi: 10.1038/sj.bmt.1703213. Bone Marrow Transplant. 2001. PMID: 11607767 Clinical Trial.
• Therapy of small cell lung cancer with emphasis on oral topotecan.

  Pirker R, Berzinec P, Brincat S, Kasan P, Ostoros G, Pesek M, Plāte S, Purkalne G, Rooneem R, Skricková J, Stanculeanu D, Timcheva C, Tzekova V, Zakotnik B, Zielinski CC, Zwitter M. Pirker R, et al. Lung Cancer. 2010 Oct;70(1):7-13. doi: 10.1016/j.lungcan.2010.05.020. Epub 2010 Jun 23. Lung Cancer. 2010. PMID: 20576312 Review.
• Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma.

  Francis JH, Marr BP, Schaiquevich P, Kellick MG, Abramson DH. Francis JH, et al. Br J Ophthalmol. 2015 Oct;99(10):1320-2. doi: 10.1136/bjophthalmol-2015-306633. Epub 2015 Apr 29. Br J Ophthalmol. 2015. PMID: 25926516 Review.